INS and type 2 diabetes mellitus: In conclusion, emodin demonstrates remarkable potential in the treatment of diabetes, it could effectively reducing FBG, 2hPG (IPGTT/ OGTT), IPITT, TC, TG, insulin levels and body weight in T2DM animal models.